Prevalence of Use of Traditional, Complementary and Alternative Medicine by the General Population: A Systematic Review of National Studies Published from 2010 to 2019

Drug Safety

Volumn 45, Issue 7, 2022, Pages 713-735

  Lee, E Lyn ^a   Richards, Noni ^b   Harrison, Jeff ^a   Barnes, Joanne ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b He Ako Hiringa   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; CINAHL; CONTROLLED STUDY; EMBASE; HERBAL MEDICINE; HUMAN; MEDLINE; PHYSICIAN; PREVALENCE; PSYCINFO; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 85133518948     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-022-01189-w     Document Type: Review

References (103)

1. Ahuriri-Driscoll A, Boulton A, Stewart A, Potaka-Osborne G, Hudson M. Ma mahi, ka ora: by work, we prosper-traditional healers and workforce development. N Zeal Med J. 2015;128(1420):34–44.
2. WHO global report on traditional and complementary medicine. Geneva: World Health Organization; 2019.
3. National Center for Complementary and Integrative Health. Complementary, alternative, or integrative health: what's in a name? 2018. https://nccih.nih.gov/health/integrative-health. Accessed 5 Jan 2020.
4. Ng JY, Dhawan T, Dogadova E, Taghi-Zada Z, Vacca A, Wieland LS, et al. Operational definition of complementary, alternative, and integrative medicine derived from a systematic search. BMC Complement Med Ther. 2022;22(1):104. DOI: 10.1186/s12906-022-03556-7
5. Gaboury I, April KT, Verhoef M. A qualitative study on the term CAM: is there a need to reinvent the wheel? BMC Altern Med. 2012;12:131. DOI: 10.1186/1472-6882-12-131
6. Holmberg C, Brinkhaus B, Witt C. Experts’ opinions on terminology for complementary and integrative medicine - a qualitative study with leading experts. BMC Altern Med. 2012;12:218. DOI: 10.1186/1472-6882-12-218
7. Reid R, Steel A, Wardle J, Trubody A, Adams J. Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use. BMC Altern Med. 2016;16:176. DOI: 10.1186/s12906-016-1143-8
8. Welz AN, Emberger-Klein A, Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med. 2018;18(1):92. DOI: 10.1186/s12906-018-2160-6
9. World Health Organisation. The Regional Strategy for Traditional Medicine in the Western Pacific (2011–2020). Geneva: World Health Organization; 2012. https://iris.wpro.who.int/bitstream/handle/10665.1/5538/9789290615590_eng.pdf.
10. Lewing B, Sansgiry SS. PHP65—examining costs, utilization, and driving factors of complementary and alternative medicine (CAM) services. Value Health. 2018;21:S97. DOI: 10.1016/j.jval.2018.04.657
11. Abdullahi AA. Trends and challenges of traditional medicine in Africa. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):115–23.
12. Sirois FM. Motivations for consulting complementary and alternative medicine practitioners: a comparison of consumers from 1997–8 and 2005. BMC Complement Altern Med. 2008;8:16. DOI: 10.1186/1472-6882-8-16
13. Foley H, Steel A, Cramer H, Wardle J, Adams J. Disclosure of complementary medicine use to medical providers: a systematic review and meta-analysis. Sci Rep. 2019;9(1):1573. DOI: 10.1038/s41598-018-38279-8
14. Ernst E. Adverse effects of spinal manipulation: a systematic review. J R Soc Med. 2007;100(7):330–8. DOI: 10.1177/014107680710000716
15. He W, Zhao X, Li Y, Xi Q, Guo Y. Adverse events following acupuncture: a systematic review of the Chinese literature for the years 1956–2010. J Altern Complement Med. 2012;18(10):892–901. DOI: 10.1089/acm.2011.0825
16. Vohra S, Cvijovic K, Boon H, Foster BC, Jaeger W, LeGatt D, et al. Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS ONE. 2012;7(9): e45196-e. DOI: 10.1371/journal.pone.0045196
17. Awortwe C, Makiwane M, Reuter H, Muller C, Louw J, Rosenkranz B. Critical evaluation of causality assessment of herb-drug interactions in patients. Br J Clin Pharmacol. 2018;84(4):679–93. DOI: 10.1111/bcp.13490
18. Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66(10):924–39. DOI: 10.1111/j.1742-1241.2012.02945.x
19. Steel A, McIntyre E, Harnett J, Foley H, Adams J, Sibbritt D, et al. Complementary medicine use in the Australian population: Results of a nationally-representative cross-sectional survey. Sci Rep. 2018;8(1):17325. DOI: 10.1038/s41598-018-35508-y
20. Esmail N. Complementary and alternative medicine: Use and public attitudes 1997, 2006 and 2016. Canada: Fraser Institute; 2017.
21. Jermini M, Dubois J, Rodondi PY, Zaman K, Buclin T, Csajka C, et al. Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Sci Rep. 2019;9(1):5078. DOI: 10.1038/s41598-019-41532-3
22. Mbizo J, Okafor A, Sutton MA, Leyva B, Stone LM, Olaku O. Complementary and alternative medicine use among persons with multiple chronic conditions: results from the 2012 National Health Interview Survey. BMC Complement Altern Med. 2018;18(1):281. DOI: 10.1186/s12906-018-2342-2
23. von Conrady DM, Bonney A. Patterns of complementary and alternative medicine use and health literacy in general practice patients in urban and regional Australia. Aust Fam Physician. 2017;46(5):316–20.
24. Ross EM, Darracq MA. Complementary and Alternative Medicine practices in military personnel and families presenting to a military emergency department. Mil Med. 2015;180(3):350–4. DOI: 10.7205/MILMED-D-14-00304
25. Jatau AI, Aung MM, Kamauzaman TH, Chedi BA, Sha’aban A, Rahman AF. Use and toxicity of complementary and alternative medicines among patients visiting emergency department: systematic review. J Intercult Ethnopharmacol. 2016;5(2):191–7. DOI: 10.5455/jice.20160223105521
26. Zollman C, Vickers A. What is complementary medicine? BMJ. 1999;319(7211):693–6. DOI: 10.1136/bmj.319.7211.693
27. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9. DOI: 10.1016/j.jclinepi.2011.11.014
28. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. DOI: 10.1136/bmj.n71
29. Harnett JE, McIntyre E, Steel A, Foley H, Sibbritt D, Adams J. Use of complementary medicine products: a nationally representative cross-sectional survey of 2019 Australian adults. BMJ Open. 2019;9(7): e024198. DOI: 10.1136/bmjopen-2018-024198
30. Pokladnikova J, Selke-Krulichova I. Prevalence of complementary and alternative medicine use in the general population in the Czech Republic. Forsch Komplementarmed. 2016;23(1):22–8.
31. Pokladnikova J, Selke-Krulichova I. The use of complementary and alternative medicine by the general population in the Czech Republic: a follow-up study. Complement Med Res. 2018;25(3):159–66. DOI: 10.1159/000479229
32. Pengpid S, Peltzer K. Utilization of traditional and complementary medicine in Indonesia: results of a national survey in 2014–15. Complement Ther Clin Pract. 2018;33:156–63. DOI: 10.1016/j.ctcp.2018.10.006
33. Baek SM, Choi SM, Seo HJ, Kim SG, Jung JH, Lee M, et al. Use of complementary and alternative medicine by self- or non-institutional therapists in South Korea: a community-based survey. Integr Med Res. 2013;2(1):25–31. DOI: 10.1016/j.imr.2013.02.001
34. Klein SD, Torchetti L, Frei-Erb M, Wolf U. Usage of complementary medicine in Switzerland: results of the Swiss Health Survey 2012 and development since 2007. PLoS ONE. 2015;10(10): e0141985. DOI: 10.1371/journal.pone.0141985
35. Chang MY, Liu CY, Chen HY. Changes in the use of complementary and alternative medicine in Taiwan: a comparison study of 2007 and 2011. Complement Ther Med. 2014;22(3):489–99. DOI: 10.1016/j.ctim.2014.03.001
36. Hunt KJ, Coelho HF, Wider B, Perry R, Hung SK, Terry R, et al. Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract. 2010;64(11):1496–502. DOI: 10.1111/j.1742-1241.2010.02484.x
37. Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH. Use of complementary and alternative medicine in Europe: health-related and sociodemographic determinants. Scand J Public Health. 2018;46(4):448–55. DOI: 10.1177/1403494817733869
38. Burnett AJ, Livingstone KM, Woods JL, McNaughton SA. Dietary supplement use among Australian adults: findings from the 2011–2012 National Nutrition and Physical Activity Survey. Nutrients. 2017;9(11):14. DOI: 10.3390/nu9111248
39. Gong W, Liu A, Yao Y, Ma Y, Ding C, Song C, et al. Nutrient supplement use among the Chinese population: a cross-sectional study of the 2010–2012 China Nutrition and Health Surveillance. Nutrients. 2018;10(11):12. DOI: 10.3390/nu10111733
40. Ock SM, Hwang SS, Lee JS, Song CH, Ock CM. Dietary supplement use by South Korean adults: Data from the national complementary and alternative medicine use survey (NCAMUS) in 2006. Nutr Res Pract. 2010;4(1):69–74. DOI: 10.4162/nrp.2010.4.1.69
41. Kang M, Kim DW, Baek YJ, Moon SH, Jung HJ, Song YJ, et al. Dietary supplement use and its effect on nutrient intake in Korean adult population in the Korea National Health and Nutrition Examination Survey IV (2007–2009) data. Eur J Clin Nutr. 2014;68(7):804–10. DOI: 10.1038/ejcn.2014.77
42. Kim JW, Lee SH, Kim JE, Han KD, Kwack TE, Kim BS, et al. The association between taking dietary supplements and healthy habits among Korean adults: results from the fifth Korea National Health and Nutritional Examination Survey (2010–2012). Korean J Fam Med. 2016;37(3):182–7. DOI: 10.4082/kjfm.2016.37.3.182
43. Awad A, Al-Shaye D. Public awareness, patterns of use and attitudes toward natural health products in Kuwait: a cross-sectional survey. BMC Altern Med. 2014;14:105. DOI: 10.1186/1472-6882-14-105
44. Kharroubi S, Chehab RF, El-Baba C, Alameddine M, Naja F. Understanding CAM use in Lebanon: findings from a national survey. Evid Based Complement Altern Med. 2018;2018:4169159. DOI: 10.1155/2018/4169159
45. Naja F, Alameddine M, Itani L, Shoaib H, Hariri D, Talhouk S. The use of complementary and alternative medicine among Lebanese adults: results from a national survey. Evid Based Complement Altern Med. 2015;2015: 682397. DOI: 10.1155/2015/682397
46. Dickinson A, Blatman J, El-Dash N, Franco JC. Consumer usage and reasons for using dietary supplements: report of a series of surveys. J Am Coll Nutr. 2014;33(2):176–82. DOI: 10.1080/07315724.2013.875423
47. Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary supplement use among US adults from 1999–2012. JAMA. 2016;316(14):1464–74. DOI: 10.1001/jama.2016.14403
48. Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994). NCHS Data Brief. 2011;(61):1–8.
49. Chen F, Du M, Blumberg JB, Chui KKH, Ruan M, Rogers G, et al. Association among dietary supplement use, nutrient intake, and mortality among U.S. adults. Ann Intern Med. 2019;170(9):604–13. DOI: 10.7326/M18-2478
50. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003–2006. J Nutr. 2011;141(2):261–6. DOI: 10.3945/jn.110.133025
51. Kennedy ET, Luo H, Houser RF. Dietary supplement use pattern of U.S. adult population in the 2007–2008 National Health and Nutrition Examination Survey (NHANES). Ecol food nutr. 2013;52(1):76–84. DOI: 10.1080/03670244.2012.706000
52. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355–61. DOI: 10.1001/jamainternmed.2013.2299
53. Metcalfe A, Williams J, McChesney J, Patten SB, Jette N. Use of complementary and alternative medicine by those with a chronic disease and the general population—results of a national population based survey. BMC Altern Med. 2010;10:58. DOI: 10.1186/1472-6882-10-58
54. Canizares M, Hogg-Johnson S, Gignac MAM, Glazier RH, Badley EM. Changes in the use practitioner-based complementary and alternative medicine over time in Canada: cohort and period effects. PLoS ONE. 2017;12(5): e0177307. DOI: 10.1371/journal.pone.0177307
55. Gunnarsdottir TJ, Orlygsdottir B, Vilhjalmsson R. The use of complementary and alternative medicine in Iceland: results from a national health survey. Scand J Public Health. 2019:1403494819863529.
56. Fox P, Coughlan B, Butler M, Kelleher C. Complementary alternative medicine (CAM) use in Ireland: a secondary analysis of SLAN data. Complement Ther Med. 2010;18(2):95–103. DOI: 10.1016/j.ctim.2010.02.001
57. Spinks J, Hollingsworth B. Policy implications of complementary and alternative medicine use in Australia: data from the National Health Survey. J Altern Complement Med. 2012;18(4):371–8. DOI: 10.1089/acm.2010.0817
58. Su D, Li L. Trends in the use of complementary and alternative medicine in the United States: 2002–2007. J Health Care Poor Underserved. 2011;22(1):296–310.
59. Upchurch DM, Rainisch BK. A sociobehavioral model of use of complementary and alternative medicine providers, products, and practices: findings from the 2007 National Health Interview Survey. Evid Based Complement Altern Med. 2013;18(2):100–7. DOI: 10.1177/2156587212463071
60. Wu CH, Wang CC, Kennedy J. Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther. 2011;33(11):1749–58. DOI: 10.1016/j.clinthera.2011.09.024
61. Wu CH, Wang CC, Tsai MT, Huang WT, Kennedy J. Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveys. Evid Based Complement Altern Med. 2014;2014: 872320.
62. Upchurch DM, Rainisch BW. The importance of wellness among users of complementary and alternative medicine: findings from the 2007 National Health Interview Survey. BMC Complement Altern Med. 2015;15:362. DOI: 10.1186/s12906-015-0886-y
63. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Report. 2015;79:1–16.
64. Nguyen LT, Davis RB, Kaptchuk TJ, Phillips RS. Use of complementary and alternative medicine and self-rated health status: results from a national survey. J Gen Intern Med. 2011;26(4):399–404. DOI: 10.1007/s11606-010-1542-3
65. Peregoy JA, Clarke TC, Jones LI, Stussman BJ, Nahin RL. Regional variation in use of complementary health approaches by U.S. adults. NCHS Data Brief. 2014;(146):1–8.
66. O’Brien SK, Malacova E, Sherriff JL, Black LJ. The prevalence and predictors of dietary supplement use in the australian population. Nutrients. 2017;9(10):21.
67. National Center for Health Statistics. National Health Interview Survey—2017 Data Release: Centers for Disease Control and Prevention; 2018. https://www.cdc.gov/nchs/nhis/nhis_2017_data_release.htm. Accessed 5 Jan 2020.
68. Quandt SA, Verhoef MJ, Arcury TA, Lewith GT, Steinsbekk A, Kristoffersen AE, et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med. 2009;15(4):331–9. DOI: 10.1089/acm.2008.0521
69. WHO traditional medicine strategy 2014–2023. World Health Organization; 2013.
70. American Association of Colleges of Osteopathic Medicine. The Difference Between U.S.-Trained Osteopathic Physicians and Osteopaths Trained Abroad. https://www.aacom.org/become-a-doctor/about-osteopathic-medicine/the-difference-between-u-s--trained-osteopathic-physicians-and-osteopaths-trained-abroad-. Accessed 5 Jan 2020.
71. Zhang Y, Wang B, Ju C, Liu L, Zhu Y, Mei J, et al. Traditional Chinese medicine for essential hypertension: a clinical evidence map. Evid Based Complement Altern Med. 2020;2020:5471931.
72. Liu M, Liu Z, Xu B, Zhang W, Cai J. Review of systematic reviews and meta-analyses investigating Traditional Chinese Medicine treatment for type 2 diabetes mellitus. J Tradit Chin Med. 2016;36(5):555–63. DOI: 10.1016/S0254-6272(15)30062-5
73. van den Driessche JJ, Plat J, Mensink RP. Effects of superfoods on risk factors of metabolic syndrome: a systematic review of human intervention trials. Food Funct. 2018;9(4):1944–66. DOI: 10.1039/C7FO01792H
74. Poswal FS, Russell G, Mackonochie M, MacLennan E, Adukwu EC, Rolfe V. Herbal teas and their health benefits: a scoping review. Plant Foods Hum Nutr. 2019;74(3):266–76. DOI: 10.1007/s11130-019-00750-w
75. Barnes J, McLachlan AJ, Sherwin CM, Enioutina EY. Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand. Expert Rev Clin Pharmacol. 2016;9(7):905–15. DOI: 10.1586/17512433.2016.1171712
76. Sammons HM, Gubarev MI, Krepkova LV, Bortnikova VV, Corrick F, Job KM, et al. Herbal medicines: challenges in the modern world. Part 2. European Union and Russia. Expert Rev Clin Pharmacol. 2016;9(8):1117–27. DOI: 10.1080/17512433.2016.1189326
77. Job KM, Kiang TK, Constance JE, Sherwin CM, Enioutina EY. Herbal medicines: challenges in the modern world. Part 4. Canada and United States. Expert Rev Clin Pharmacol. 2016;9(12):1597–609. DOI: 10.1080/17512433.2016.1238762
78. Dixon A. Regulating complementary medical practitioners—an international review. 2008. https://www.kingsfund.org.uk/sites/default/files/Research%20summary1.pdf. Accessed 5 Jan 2020.
79. Stone J, Matthews J. Complementary medicine and the law. New York: Oxford University Press; 1996.
80. Horrigan B, Lewis S, Abrams DI, Pechura C. Integrative medicine in America—how integrative medicine is being practiced in clinical centers across the United States. Glob Adv Health Med. 2012;1(3):18–94. DOI: 10.7453/gahmj.2012.1.3.006
81. Pirotta MV, Cohen MM, Kotsirilos V, Farish SJ. Complementary therapies: have they become accepted in general practice? Med J Aust. 2000;172(3):105–9. DOI: 10.5694/j.1326-5377.2000.tb127932.x
82. Stussman BJ, Nahin RR, Barnes PM, Ward BWUS. physician recommendations to their patients about the use of complementary health approaches. J Altern Complement Med. 2020;26(1):25–33. DOI: 10.1089/acm.2019.0303
83. Cohen MM, Penman S, Pirotta M, Da Costa C. The integration of complementary therapies in Australian general practice: results of a national survey. J Altern Complement Med. 2005;11(6):995–1004. DOI: 10.1089/acm.2005.11.995
84. Uppsala Monitoring Centre. The herbal anatomical therapeutic chemical classification system. 2020. https://www.who-umc.org/whodrug/whodrug-portfolio/whodrug-global/herbal-atc/. Accessed 5 Jan 2020.
85. International statistical classification of diseases and related health problems (ICD-11). World Health Organization; 2020. https://icd.who.int/en.
86. Raterman K. The potential of blockchain for herbal supply chain management. HerbalGram. 2019;123:52–61.
87. Heinrich M, Scotti F, Booker A, Fitzgerald M, Kum KY, Löbel K. Unblocking high-value botanical value chains: Is there a role for blockchain systems? Front Pharmacol. 2019;10:396. DOI: 10.3389/fphar.2019.00396
88. Medicines and Healthcare products Regulatory Agency. Precautionary recall—six batches of St John’s Wort Tablets: Medicines and Healthcare products Regulatory Agency, UK; 2016. https://www.gov.uk/government/news/precautionary-recall-six-batches-of-st-johns-wort-tablets.
89. Australian Therapeutic Goods Administration. Complementary medicine regulation basics. https://www.tga.gov.au/complementary-medicine-regulation-basics. Accessed 5 Jan 2020.
90. Guidance - Herbal medicines granted a traditional herbal registration: Medicines and Healthcare Products Regulatory Agency; 2019. https://www.gov.uk/government/publications/herbal-medicines-granted-a-traditional-herbal-registration-thr/herbal-medicines-granted-a-traditional-herbal-registration. Accessed 5 Jan 2020.
91. Farah MH, Olsson S, Bate J, Lindquist M, Edwards R, Simmonds MS, et al. Botanical nomenclature in pharmacovigilance and a recommendation for standardisation. Drug Saf. 2006;29(11):1023–9. DOI: 10.2165/00002018-200629110-00002
92. Barnes J. Adverse drug reactions and pharmacovigilance of herbal medicines. In: Talbot J, Aronson JK, editors. Stephens’ detection and evaluation of adverse drug reactions: principles and practice. 6th ed. Wiley; 2012.
93. MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust. 2006;184(1):27–31. DOI: 10.5694/j.1326-5377.2006.tb00092.x
94. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;18:1–14.
95. Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196(1):50–3. DOI: 10.5694/mja11.10698
96. Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother. 2007;41(10):1617–24. DOI: 10.1345/aph.1K221
97. Levy I, Attias S, Ben-Arye E, Goldstein L, Schiff E. Adverse events associated with interactions with dietary and herbal supplements among inpatients. Br J Clin Pharmacol. 2017;83(4):836–45. DOI: 10.1111/bcp.13158
98. Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician. 1999;59(5):1239–45.
99. Bowe S, Adams J, Lui CW, Sibbritt D. A longitudinal analysis of self-prescribed complementary and alternative medicine use by a nationally representative sample of 19,783 Australian women, 2006–2010. Complement Ther Med. 2015;23(5):699–704. DOI: 10.1016/j.ctim.2015.06.011
100. Niggemann B, Gruber C. Side-effects of complementary and alternative medicine. Allergy. 2003;58(8):707–16. DOI: 10.1034/j.1398-9995.2003.00219.x
101. Han J, Xian Z, Zhang Y, Liu J, Liang A. Systematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms. Front Pharmacol. 2019;10:648. DOI: 10.3389/fphar.2019.00648
102. Council for International Organizations of Medical Sciences (CIOMS) Working Group. Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting. Geneva; 2020.
103. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7. DOI: 10.7326/0003-4819-147-8-200710160-00010